Literature DB >> 24888739

Hypothesis testing for an extended cox model with time-varying coefficients.

Takumi Saegusa1, Chongzhi Di2, Ying Qing Chen3.   

Abstract

The log-rank test has been widely used to test treatment effects under the Cox model for censored time-to-event outcomes, though it may lose power substantially when the model's proportional hazards assumption does not hold. In this article, we consider an extended Cox model that uses B-splines or smoothing splines to model a time-varying treatment effect and propose score test statistics for the treatment effect. Our proposed new tests combine statistical evidence from both the magnitude and the shape of the time-varying hazard ratio function, and thus are omnibus and powerful against various types of alternatives. In addition, the new testing framework is applicable to any choice of spline basis functions, including B-splines, and smoothing splines. Simulation studies confirm that the proposed tests performed well in finite samples and were frequently more powerful than conventional tests alone in many settings. The new methods were applied to the HIVNET 012 Study, a randomized clinical trial to assess the efficacy of single-dose Nevirapine against mother-to-child HIV transmission conducted by the HIV Prevention Trial Network.
© 2014, The International Biometric Society.

Entities:  

Keywords:  Censoring; Clinical trials; HIV/AIDS; Log‐rank test; Score test

Mesh:

Substances:

Year:  2014        PMID: 24888739      PMCID: PMC4247822          DOI: 10.1111/biom.12185

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  7 in total

1.  Flexible weighted log-rank tests optimal for detecting early and/or late survival differences.

Authors:  Lang Wu; Peter B Gilbert
Journal:  Biometrics       Date:  2002-12       Impact factor: 2.571

2.  Smoothing spline-based score tests for proportional hazards models.

Authors:  Jiang Lin; Daowen Zhang; Marie Davidian
Journal:  Biometrics       Date:  2006-09       Impact factor: 2.571

3.  A partial likelihood approach to smooth estimation of dynamic covariate effects using penalised splines.

Authors:  Denise Brown; Göran Kauermann; Ian Ford
Journal:  Biom J       Date:  2007-06       Impact factor: 2.207

4.  An adaptive weighted log-rank test with application to cancer prevention and screening trials.

Authors:  S G Self
Journal:  Biometrics       Date:  1991-09       Impact factor: 2.571

5.  Exploring the nature of covariate effects in the proportional hazards model.

Authors:  T Hastie; R Tibshirani
Journal:  Biometrics       Date:  1990-12       Impact factor: 2.571

6.  Spline-based tests in survival analysis.

Authors:  R J Gray
Journal:  Biometrics       Date:  1994-09       Impact factor: 2.571

7.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

Authors:  J Brooks Jackson; Philippa Musoke; Thomas Fleming; Laura A Guay; Danstan Bagenda; Melissa Allen; Clemensia Nakabiito; Joseph Sherman; Paul Bakaki; Maxensia Owor; Constance Ducar; Martina Deseyve; Anthony Mwatha; Lynda Emel; Corey Duefield; Mark Mirochnick; Mary Glenn Fowler; Lynne Mofenson; Paolo Miotti; Maria Gigliotti; Dorothy Bray; Francis Mmiro
Journal:  Lancet       Date:  2003-09-13       Impact factor: 79.321

  7 in total
  2 in total

1.  Immuno-oncology Trial Endpoints: Capturing Clinically Meaningful Activity.

Authors:  Valsamo Anagnostou; Mark Yarchoan; Aaron R Hansen; Hao Wang; Franco Verde; Elad Sharon; Deborah Collyar; Laura Q M Chow; Patrick M Forde
Journal:  Clin Cancer Res       Date:  2017-09-01       Impact factor: 12.531

2.  Static internal representation of dynamic situations reveals time compaction in human cognition.

Authors:  José Antonio Villacorta-Atienza; Carlos Calvo Tapia; Sergio Díez-Hermano; Abel Sánchez-Jiménez; Sergey Lobov; Nadia Krilova; Antonio Murciano; Gabriela E López-Tolsa; Ricardo Pellón; Valeri A Makarov
Journal:  J Adv Res       Date:  2020-08-14       Impact factor: 10.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.